Might arsenic trioxide be useful in the treatment of advanced myelodysplastic syndromes?

Haematologica. 2000 Sep;85(9):1002-3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Disease
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects
  • Arsenic Trioxide
  • Arsenicals / pharmacology
  • Arsenicals / therapeutic use*
  • Bone Marrow Cells / drug effects
  • Cell Culture Techniques
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Growth Inhibitors / pharmacology
  • Growth Inhibitors / therapeutic use
  • Humans
  • Leukemia, Myeloid / blood
  • Leukemia, Myeloid / drug therapy
  • Leukemia, Myeloid / pathology
  • Leukocytes, Mononuclear / drug effects
  • Myelodysplastic Syndromes / blood
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / pathology
  • Oxides / pharmacology
  • Oxides / therapeutic use*

Substances

  • Antineoplastic Agents
  • Arsenicals
  • Growth Inhibitors
  • Oxides
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Arsenic Trioxide